MedTrace Logo

The Rainbow Study - the Effect of Feedback on Asthmatic Symptom Perception

NCT06702735 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-11-25

No results posted yet for this study

Summary

Asthma is a common childhood disease that is characterized by chronic airway inflammation and episodic expiratory airflow obstruction. Asthma symptoms can impair participation in play and sports and have a negative impact on quality of life. It can be challenging for children to adequately feel and report their symptoms. Some children experience more symptoms than expected based on lung function during these symptoms, whereas others experience less symptoms than expected. This is also called 'symptom perception'.

A tool was developed to visualize symptoms, lung function and accessory symptom perception: The Rainbow tool. The aim of this study was to identify asthmatic children with a poor perception and investigate if their symptom perception could be improved by regular lung function measurements and personal feedback based on the Rainbow Tool.

Hypothesis: Measuring lung function en symptoms and provide personal feedback on perception based on the Rainbow tool has a positive effect on perception of asthma-related symptoms in asthmatic children.

Conditions

  • Asthma in Children
  • Exercise Induced Asthma

Interventions

BEHAVIORAL

Rainbow tool

The Rainbow tool visualizes perception based on lung function measurements and VAS scores.

BEHAVIORAL

Feedback

Feedback sessions with health care professional based on the Rainbow tool.

Sponsors & Collaborators

  • Medisch Spectrum Twente

    lead OTHER

Principal Investigators

  • Vera Hengeveld, MD · Medisch Spectrum Twente

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-16
Primary Completion
2024-02-01
Completion
2025-05-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06702735 on ClinicalTrials.gov